Genoplan  logo — 유전자 정보의 대중화를 선도하는 글로벌 생명공학 기업 제노플...

Genoplan

유전자 정보의 대중화를 선도하는 글로벌 생명공학 기업 제노플랜코리아 입니다.

Founded 2014 Korea South Korea South 16 employees Series C Total: $27.83M AI, Analytics +5

General Information

Company Name Genoplan
Founded Year 2014
Location Korea South Korea South
Founders / Decision Makers
Team member
Employees 16
Industries AI, Analytics, Biotechnology +4
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Genoplan . To contact Genoplan , visit genoplan.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Genoplan

As an investor, I have analyzed Genoplan, a South Korean biotechnology startup specializing in DNA testing. Founded in 2014, the company uses saliva samples to conduct genetic analysis and offer personalized lifestyle advice, including diet, health food, workout, and cosmetics recommendations. With operations in Seoul, Korea, and Fukuoka and Tokyo, Japan, Genoplan has attracted significant investment, including a $9.20M Series C investment on 28 December 2020. The company's focus on utilizing AI technology to enhance predictive capabilities and expand personalized services demonstrates its potential for growth and differentiation in the biotechnology, health care, and insurtech industries. Genoplan's ability to cater to individual genetic predispositions enabling businesses to plan personalized services and products positions it as a leader in democratizing genetic information.

Taxonomy: Genomics, DNA Sequencing, AI Technology, Precision Medicine, Lifestyle, Health & Wellness, Personalized Medicine, Population Genomics, Deep Learning, Health Tech, Genetic Analysis, Health Advice, Beauty Tech

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $9.20M -
28 Dec 2020
Series B $1.00M 3
DAYLI Partners, PIA Investment Management +1
20 Nov 2018
Series B $13.00M 3
PIA Investment Management, DAYLI Financial Group +1
29 Jun 2018
Series A $4.40M 4
SparkLabs Accelerator, Samsung Ventures +2
14 Mar 2016
Seed Round $225.00K -
03 Jul 2015

Genoplan Alternatives & Competitors

View All Alternatives
Genoplan vs
NGeneR
NGeneR Denmark

Make every day progress for better health.

2-10 employees
Biotechnology, Health Care
Genoplan vs
HiDNA
HiDNA Turkey

DNA Based Future!

5 employees
Biotechnology, Deep Tech
Genoplan vs

Live a healthier, longer life.

Venture round
90 employees
Biotechnology, Health Care

FAQ About Genoplan

유전자 정보의 대중화를 선도하는 글로벌 생명공학 기업 제노플랜코리아 입니다.
Genoplan was founded in 2014.
Genoplan is headquartered in Korea South.
Genoplan operates in AI, Analytics, Biotechnology, Health Care, Insurtech, Life Sciences and Machine Learning. Its work centres on Genomics, DNA Sequencing, AI Technology and Precision Medicine.
Genoplan has approximately 16 employees.
Genoplan has completed 5 funding rounds, raising a total of $27.83M. The latest funding stage is Series C.
Top alternatives and competitors to Genoplan include NGeneR, HiDNA, Human Longevity, Inc., Aniling, 54gene. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genoplan and NGeneR are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Genoplan , https://bouncewatch.com/company/genoplan, updated 9 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes